Outset Medical (OM) Receives Nasdaq Notice, Shares No Longer Meet Minimum Bid Requirement, Class Action Pending After FDA Warning - Hagens Berman

SAN FRANCISCO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Hagens Berman encourages Outset Medical (NASDAQ: OM) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may assist the investigation to contact its attorneys. On September 27, 2024, Outset Medical announced that it received notice from the Listing Qualifications staff of Nasdaq that "because the closing bid price for the Company's common stock had fallen below $1.00 per share for 30 consecu ...